Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

3-D Printing Enables Research On Bioprinted Human Organs

This article was originally published in The Gray Sheet

Executive Summary

Organovo has delivered its first 3-D printed liver tissue to an outside lab for further analysis, highlighting the advent of synthetically produced human organs. Scientists who received a government grant to do research in that arena told “The Gray Sheet” that bioprinting living human cells made it all possible.

You may also be interested in...



Director Collins Implores Congress To Set Predictable NIH Funding Growth

The best way to accelerate medical cures, National Institutes of Health Director Francis Collins tells a congressional 21st Century Cures coalition, is to make sure that NIH researchers are supplied with a steady, predictable source of grant funding.

3-D Printed Implants Hit The Market, Pave The Way For More Personalized Devices

Companies have recently started to launch implants constructed via 3-D printing to increase product customization and to save on costs. FDA says the additive manufacturing techniques are a promising form of personalized medicine.

‘The Sky’s The Limit’ For 3-D Printed Medical Devices, FDA Says

In an interview with “The Gray Sheet,” staff in CDRH’s Office of Science and Engineering Laboratories discuss the center’s research studies on 3-D printers used to manufacture medical devices and describe the challenges and opportunities that lie ahead.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT033552

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel